Physician profile
Melissa Wong
NPI 1194284166
$4,388.22
in general payments reported to CMS, 2019-2025
18 companies · $2,948 in 2025
The $2,948 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,441 · 2025: $2,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354 · Travel and Lodging: $1,935 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.62 |
| Travel and Lodging | $1,934.61 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,556.06 | 2024-2025 | Axonics, Tactra, Ams 700 |
| Intuitive Surgical, INC. | $1,376.34 | 2025 | |
| Teleflex LLC | $304.40 | 2025 | Barrigel, Urolift |
| Sumitomo Pharma America, INC. | $268.56 | 2024-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $240.73 | 2025 | |
| Endo USA, INC. | $138.97 | 2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $127.74 | 2024 | Xtandi |
| Janssen Biotech, INC. | $60.21 | 2024-2025 | Erleada |
| Olympus America INC. | $52.50 | 2024 | Itind System |
| Abbvie INC. | $42.85 | 2025 | |
| Pfizer INC. | $40.12 | 2024-2025 | |
| Photocure INC | $38.61 | 2024-2025 | Cysview |
| Axonics, INC. | $28.74 | 2024 | Axonics |
| Bluewind Medical | $28.33 | 2024 | Revi |
| Ferring Pharmaceuticals INC. | $24.66 | 2025 | Adstiladrin |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $23.28 | 2025 | |
| Myriad Genetic Laboratories, INC. | $21.02 | 2025 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $15.10 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.